Sarah Haywood

Welcome – Sarah Haywood, CEO, MedCity

Hello, or should I say konnichiwa, as we return from Japan following our successful trip this month. We led a delegation of UK scientists and companies to Tokyo and Yokohama for a packed week of events, speaking slots, and partnering sessions. Read more about the visit below.

Great news this month as DigitalHealth.London Accelerator company Lumeon is now participating in the Cedars-Sinai Accelerator Powered by Techstars. This is off the back of a trip they participated in with Digital Health.London and MedCity to Los Angeles this summer, and will see them collaborating with Cedars-Sinai to identify digital care pathways that can be deployed in care settings throughout the US.

It was also great to see MedCity was highlighted in a Deloitte report commissioned by HEFCE to analyse the impact and return on investment that their Catalyst funding is delivering. I have written a blog about how invaluable this funding has been to establish MedCity and to support our life sciences programmes.

And finally, Neelam Patel and Sinéad Kearns are heading to BioEurope in Berlin from 6 – 8 November, so drop them a line or find them on the partnering system if you would like to meet. I am also getting ready to speak at the FT Global Pharma and Biotech conference next week on what makes clusters ticks, and we are preparing for Genesis where we are hosting a breakfast session on UK-Japan opportunities. I look forward to catching up with people there.

MedCity’s Spotlight on…Blue Earth Diagnostics

Each month we will share a Golden Triangle company that is making waves in the life sciences sector. We kick off by speaking with Jonathan Allis, CEO at Blue Earth Diagnostics, based at the Oxford Science Park.

Read his interview here

Malcolm Lowe-Lauri
ANNUAL REPORT

Nobel Prize for Cambridge

Fantastic news as Richard Henderson from the MRC’s Laboratory of Molecular Biology wins a Nobel Prize “for developing cryo-electron microscopy for the high-resolution structure determination of biomolecules in solution”.

Find out more

Successful UK visit to Japan

We were in Tokyo and Yokohama this month, leading our biggest life sciences delegation to Japan, to promote the UK’s life sciences expertise and partner with our Japanese counterparts.

Read Sarah’s blog on the visit 

Capital Cell

More space to come at Babraham 

BioMed Realty has signed a long-term lease on eight acres of BBSRC-owned land at the Babraham Research Campus in Cambridge, which will enable the ground-up construction of two new buildings for growing bioscience-based companies at the campus.

Read more      

Landmark agreement for new Whitechapel space

The creation of a new cutting-edge life sciences facility to bring new treatments to patients faster has moved a step closer as a landmark agreement has been signed by Queen Mary University of London (QMUL) and Barts Health NHS Trust.

 Read more

Oxford Health

Closing the gap between mental and physical health

A pioneering King’s Health Partners initiative to identify and treat mental illness in people with physical health conditions is now running in more than 50 hospital clinics across Lambeth and Southwark.

Read more

Patrick heads off for pastures new

Angels in MedCity is three years old this month! We spoke with Patrick O’Brien, who led the programme until his departure from MedCity last week, to find out his highlights and his tips for angel investors and entrepreneurs.

Read more

Capital Cell
Funding
Evidence: The Search for the Holy Grail

Neelam blogs for DigitalHealth.London about the importance of reliable evidence in the digital health landscape.

Find out the areas that regulators, payers, and SMEs consider important in having a good evidence base and who can help in research and trials.

Read more 

DigitalHealth.London

Calling digital health SMEs looking to grow!

DigitalHealth.London has been commissioned by RYSE Asset Management LLP to provide screening and evaluation of promising early-stage digital health businesses that show the potential to address health and care needs. The campaign starts soon – find out more below!

Read more and get involved 

Launched in April 2014, MedCity is a collaboration between the Mayor of London, Imperial College Academic Health Science Centre, King’s Health Partners, UCL Partners, Cambridge University Health Partners and Oxford Academic Health Science Centre. 

The next edition of MedCity Update will be sent in November 2017.

Twitter
Website